Need professional-grade analysis? Visit stockanalysis.com
$3.74B
148.50
417
N/A
Microport Cardioflow Medtech Corp (2160) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD2.93, down 6.98% from the previous close.
Over the past year, 2160 has traded between a low of HKD0.77 and a high of HKD4.20. The stock has gained 218.5% over this period. It is currently 30.2% below its 52-week high.
Microport Cardioflow Medtech Corp has a market capitalization of $3.74B, with a price-to-earnings ratio of 148.50.
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It's product portfolio includes transcatheter aortic valves, left atrial appendage closure, transcatheter mitral valves, transcatheter tricuspid valves, and surgical accessories, as well as procedural accessories; and VitaFlow, VitaFlow Liberty, VitaFlow Liberty Flex, Alwide Plus, AccuSniperTM, AnchorMan LAAC System, AnchorMan LAAA System, and various TAVI, TMV, TTV, and LAA products. In addition, the company provides technical consultation and technical services for medical devices clinical trial. MicroPort CardioFlow Medtech Corporation was founded in 2009 and is headquartered in Shanghai, China.
Side-by-side comparison against top Healthcare peers.